KLKB1 encodes prekallikrein, a precursor of plasma kallikrein, and therefore its knockout permanently reduces plasma kallikrein activity and halts the production of bradykinin to prevent HAE attacks. The gene discussed is KLK4; the disease is hereditary angioedema.